Published in Medical Patent Law Weekly, November 7th, 2007
Dr. Keith Dredge, Progen's Preclinical Development Manager, is presenting the data in a poster entitled, "Heparan Sulfate Mimetics-Potent Angiogenesis Inhibitors for Cancer Therapeutics" at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, in San Francisco.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly